Weighing in on Optimal Management of VTE in Patients With Obesity

Share

Program Content

Activities

  • Weighing in on Optimal Management of VTE in Patients With Obesity
    Weighing in on Optimal Management of VTE in Patients With Obesity
    PDF
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 15, 2022

    Expires: April 14, 2023

  • Weighing in on Optimal Management of VTE in Patients With Obesity
    Weighing in on Optimal Management of VTE in Patients With Obesity
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 15, 2022

    Expires: April 14, 2023

  • VTE in Patients With Obesity
    Weighing in on Optimal Management of VTE in Patients With Obesity
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 15, 2022

    Expires: April 14, 2023

  • Preventing Recurrent VTE in Persons with Obesity
    Preventing Recurrent VTE in Persons with Obesity
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 09, 2022

    Expires: May 08, 2023

  • Managing VTE After Bariatric Surgery
    Managing VTE After Bariatric Surgery
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 23, 2022

    Expires: May 22, 2023

Faculty

cover img faculity

Christian T. Ruff, MD, MPH

Associate Professor of Medicine
Harvard Medical School
Director of General Cardiology
Brigham and Women's Hospital
Boston, Massachusetts

cover img faculity

Daniel Thibodeau, DHSc, MHP, PA-C

Professor
Physician Assistant Program
Doctor of Medical Science Program
Eastern Virginia Medical School
Physician Assistant
Division of Cardiology
Sentara Medical Group
Sentara Health Systems
Norfolk, Virginia

Provided by

ProCE Banner

Supporters

Bristol Myers Squibb

Bristol Myers Squibb

Bristol Myers Squibb

Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.

Pfizer Alliance

Pfizer Alliance